Abstract-Diabetic nephropathy is strongly associated with both increased oxidative stress and kidney tissue hypoxia. The increased oxidative stress causes increased kidney oxygen consumption resulting in kidney tissue hypoxia. To date, it has been difficult to determine the role of kidney hypoxia, per se, for the development of nephropathy. We tested the hypothesis that kidney hypoxia, without confounding factors such as hyperglycemia or elevated oxidative stress, results in nephropathy.
P
rogressive loss of kidney function leads to end-stage renal disease (ESRD), requiring dialysis or kidney transplantation. Diabetes mellitus, hypertension, glomerulonephritis, and cystic kidney disease are all major causes for ESRD. 1 Approximately 45% of all cases of ESRD are caused by diabetes mellitus, 2 and the number of affected patients will continue to increase because the prevalence of diabetes mellitus is projected to increase from 171 million in 2000 to 366 million in 2030. 3 Development of diabetic nephropathy is closely associated with increased levels of oxidative stress, 4, 5 and alterations in kidney metabolism and oxygen handling. [6] [7] [8] These functional alterations precede the structural changes of the kidney. 10, 11 Fine et al 9 suggested already in 1998 that kidney hypoxia is a mediator of progressive kidney disease, and chronic tubulointerstitial hypoxia is now commonly acknowledged as a pathway to ESRD. [10] [11] [12] [13] [14] [15] Although the kidneys receive 25% of cardiac output, and the blood in the renal vein is well oxygenated, 16 the kidney oxygen tension (Po 2 ) is markedly lower than arterial Po 2 , and the renal medulla operates in a hypoxic milieu already during physiological conditions. 17, 18 It should be noted that the kidney does not display the same relationship between oxygen demand and supply as other organs, for example, the brain. Increasing oxygen delivery (DO 2 ) to the kidney by increasing renal blood flow (RBF) is likely to result in a simultaneously increased tubular electrolyte load attributable to increased glomerular filtration rate (GFR). This will increase active tubular transport that, per se, increases the energy demand resulting in increased kidney oxygen consumption (QO 2 ). Therefore, increased intrarenal oxygen metabolism will inevitably result in kidney tissue hypoxia and potentially contribute to the However, it is difficult to mechanistically separate intrarenal tissue hypoxia from oxidative stress because it is increased oxidative stress that causes the initial increase in kidney QO 2 , which results in the lower tissue Po 2 in these kidneys. 7, 20 In kidneys from diabetic rats, increased mitochondrial uncoupling protein-2 activity increases mitochondrial QO 2 . 21 By releasing protons across the mitochondrial inner membrane independently of ATP production, uncoupling protein-2 controls the mitochondrial membrane potential and therefore also superoxide formation. Mitochondrial uncoupling is therefore an antioxidant mechanism but with the side effect of significantly elevated QO 2 . The chemical mitochondrial uncoupler, 2,4-dinitrophenol (DNP), also increases mitochondrial QO 2 without increasing ATP production. DNP was therefore used as a weight loss therapy in the early 1930s but was banned from the market in 1938 because of causing cataract and overdosing fatalities. 23, 24 In this study, we tested the hypothesis that intrarenal hypoxia, per se, without confounding factors such as hyperglycemia and oxidative stress, can induce nephropathy.
Material and Methods
All animal procedures were approved by the Uppsala animal ethics committee and were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Male Sprague-Dawley rats were treated with DNP (30 mg per day per kg bodyweight, 25 1 mL dissolved in 1.5% methyl cellulose) or vehicle by gavage for 30 days. During the treatment period, the body weight, weight gain, and food and water intake were monitored and, after the treatment period, the in vivo kidney function was evaluated in terms of GFR, RBF, kidney QO 2 , kidney Po 2 , DO 2, kidney concentrations of glucose and glycogen (analyzed using bioluminescence imaging), 26 and tubular reabsorption of Na + and proteinuria. In each group, randomly selected animals (n=6-8) were analyzed for urinary excretion of thiobarbituric acid reactive substances, kidney cortex content of protein carbonyls, tubular damage indicated by vimentin staining, and infiltration of immune cells by mouse monoclonal macrophage CD68 antibody (ED-1) staining. Expressions of oxygen-regulated genes were analyzed by reverse transcription polymerase chain reaction. 27 Nephropathy was defined as the development of proteinuria and histological alterations. See the online-only Data Supplement for a detailed Methods section.
Statistical analysis was performed using Student t test. P<0.05 (2-sided) was considered statistically significant, and all values are presented as mean±SEM.
Results
Treatment with DNP did not statistically change body weight, blood glucose, kidney weight, mean arterial pressure, RBF, GFR, or tubular reabsorption of Na + . Renal DO 2 , hemoglobin content, and food and water intake was increased, and transported Na + per consumed oxygen was reduced in rats treated with DNP (Table 1) .
DNP increased QO 2 ( Figure 1 ) and reduced kidney content of glycogen and glucose ( Figure 2A and 2B). The increased metabolism induced by DNP resulted in tissue hypoxia in both kidney cortex and medulla ( Figure 3 ). Furthermore, DNP treatment induced proteinuria and increased vimentin staining and infiltration of ED-1-positive cells ( Figure 4A -4C). Importantly, chronic DNP treatment did not statistically affect markers of oxidative stress in either urine or in kidney tissue ( Figure 5A and 5B).
Acute infusion of DNP to determine its acute toxicity did not statistically alter urinary protein excretion in either controls (46.9±7.7 versus 50.9±5.9 µg/min; ns) or in chronically DNP-treated animals (76.9±7.6 versus 57.4±10.2 µg/min; ns) compared with baseline. However, acute DNP administration decreased both cortical and medullary kidney Po 2 in controls (34±2 versus 44±1 and 26±1 versus 30±2 mm Hg, respectively; both P<0.05) but did not statistically affect any of the other investigated parameters in any of the 2 groups (data not shown).
Discussion
This study demonstrates that kidney hypoxia, attributable to increased kidney QO 2 , induces nephropathy without confounding factors such as hyperglycemia or oxidative stress. The results from the present study may therefore demonstrate that kidney tissue hypoxia, per se, is sufficient to induce similar nephropathy as commonly observed in animal models of experimental diabetic and hypertensive kidney disease as well as in the corresponding patient populations.
There is growing support for kidney tissue hypoxia as a main pathogenic mechanism for development of chronic kidney disease, both in diabetes mellitus and other conditions. [10] [11] [12] [13] [14] [15] Indeed, decreased kidney Po 2 has been demonstrated in 35 hypertensive nephrosclerosis, and chronic glomerulonephritis. 36 Fine et al 9 proposed that the initial glomerular injury leading to decreased RBF in peritubular capillaries causes decreased tissue Po 2 , which promotes tubulointerstitial fibrosis. The remaining glomerular and peritubular capillaries are subjected to increased RBF and hydrostatic pressure, which in turn increases damage and promotes further development of fibrosis. Consequently, both decreased and increased RBF in the peritubular capillaries would lead to tubulointerstitial hypoxia. They proposed a critical interstitial hypoxia level that resulted in the progressive loss of kidney function. 9 Indeed, loss of peritubular capillaries has been reported in diabetes mellitus 37 and ischemic injury. 38 Furthermore, development of hypoxia and tubulointerstitial fibrosis correlates with decreasing GFR in patients with chronic kidney disease. 36 Also, it has been reported that cortical interstitial fibrosis, reduced proximal tubule epithelium volume, and atrophied proximal tubules all correlate with GFR at the time of biopsy. 39 In the present study, we observed increased vimentin staining, a marker of tubular damage, 40 in the animals treated with DNP. Vimentin has been used to investigate the degree of tubulointerstitial damage in both patients 41, 42 and animal models. 43 Importantly, we also detected increased urinary protein leakage in the DNP-treated animals, which is commonly regarded as a good predictor for progressive nephropathy. 44 It is possible that the hypoxic injury results not only in increased protein permeability across the glomerular capillary but also negatively affects protein reabsorption in the proximal tubule. Both these mechanisms promote proteinuria. It has also been demonstrated that albumin can induce elevated cytokine levels in tubular cells and thereby promote apoptosis. 45, 46 Proteinuria may therefore be a self-sustained pathway to accelerate nephropathy. Indeed, it has been demonstrated that the level of proteinuria correlated to a more rapid loss of kidney function in patients with chronic kidney disease. 44, 47 Despite increased DO 2 in the chronically DNP-treated animals, there was still intrarenal tissue hypoxia. It may be speculated that the reason as to why kidneys with elevated QO 2 do not benefit from increased DO 2 may be attributable to arteriovenous precapillary shunting of oxygen. In the kidney, arteries run in parallel to veins, which constitutes the basis for a morphological shunt. Thus, increased kidney QO 2 results in a larger arteriovenous oxygen gradient, which facilitates shunting and prevents increased DO 2 to counteract the intrarenal tissue hypoxia. In pioneering studies, Levy et al 48, 49 injected labeled erythrocytes in supersaturated oxygen buffer and measured the transit time for the erythrocytes and the oxygen peak to travel across to the renal vein. They reported that the oxygen peak appeared on average 1.25 seconds earlier than the erythrocytes, and it was concluded that the oxygen traveled a shorter distance compared with the erythrocytes that were restricted to the vasculature. 48, 49 The only possible explanation is a functional arteriovenous shunt of oxygen, which has also been supported by later reports by others. 17, 20, 50, 51 In the present study, treatment with DNP for 30 days resulted in nephropathy evident as proteinuria, increased vimentin expression, and infiltration of immune cells. However, DNP is considered an environmental toxin and may be nephrotoxic, per se. Indeed, reports of proteinuria after treatment with DNP exist. Two women treated with a low-dose DNP for 35 to 37 days and dogs treated with DNP for 6 months all developed proteinuria. [52] [53] [54] Any influence of direct nephrotoxic effects of DNP for the observed results in the present study cannot be excluded because other mitochondrial uncouplers, such as carbonyl cyanide p-trifluoromethoxy-phenylhydrazone, have a similar chemical structure and most likely similar toxicity. Therefore, future experiments in which the possible toxicity of DNP can be excluded, possibly by reversing the hypoxia after DNP treatment, are needed to conclusively solidify the role of hypoxia, per se, as the main mechanism for development of nephropathy. Importantly, acute infusion of DNP resulted in decreased cortical and medullary Po 2 but did not affect the urinary protein excretion in the present study. This indicates that DNP exerts an effect on renal metabolism but without any acute nephrotoxicity. It is also unlikely that the nephropathy attributable to chronic DNP treatment is the result of ATP depletion because both groups had similar GFR and Na + excretion, which is in good agreement with previous reports. 55, 56 As active tubular reabsorption of Na + accounts for ≈85% of total kidney QO 2 , 57 an ATP deficiency would likely be manifested as increased urinary Na + excretion and deranged whole-body Na + homeostasis. In accordance, the kidney content of glycogen and glucose was decreased, but not depleted, by the chronic DNP treatment. These results collectively confirm that DNP elevates mitochondrial usage of these energy substrates, but that the kidney still has the necessary substrate supply to sustain sufficient ATP production to uphold tubular function. We therefore propose that DNP is indeed nephrotoxic, but the mechanism consists of kidney hypoxia resulting in tubulointerstitial damage and proteinuria. It has been reported that DNP protects against ischemiareperfusion injury in the heart 58 and cortical neurons, 59 which is likely because of reduced oxidative stress originating from mitochondrial sources. However, peripheral neuropathy has been reported in patients after long-term DNP treatment. 60 In the present study, we did not observe any obvious signs of neuropathy or altered behavior from the DNP treatment. Furthermore, blood flow increases in response to increased QO 2 in most organs and tissues. Thus, the DNP-induced increased QO 2 is likely to have most profound effects on the intrarenal oxygen availability because the blood flow does not increase in response to increased QO 2 in the kidney.
The present study is in accordance with numerous studies indicating chronic tubulointerstitial hypoxia as the important mediator of nephropathy. [10] [11] [12] [13] [14] [15] Interestingly, Navajo Indians living at high altitude had 1.8-fold higher prevalence of ageadjusted nondiabetes-related ESRD compared with both the general population and Native Americans in the United States. 61 Furthermore, patients with type 2 diabetes mellitus living at 1700 m above sea level present with elevated baseline urinary protein excretion and increased prevalence of proteinuria compared with corresponding patients living at sea level. 62 It should be noted that these differences are independent of glycemic control, lipidemia status, mean arterial pressure, or incidence of retinopathy. Thus, the available literature suggests that kidney tissue hypoxia is a key player for the development of chronic kidney disease in numerous pathological conditions. 7, 20, [28] [29] [30] [31] [32] [33] [34] [35] [36] In conclusion, the present study provides additional support that kidney tissue hypoxia, resulting from increased QO 2 induced by mitochondria uncoupling, can result in tubulointerstitial damage and proteinuria. Kidney hypoxia may therefore be an important pathogenic mechanism for the development of nephropathy.
Perspectives
Metabolic changes are likely to occur early and precede later irreversible histological alterations. Thus, being able to detect and target these early changes in the intrarenal oxygen metabolism The results from the present study demonstrate that increased mitochondrial QO 2 , without confounding factors such as hyperglycemia or oxidative stress, may be sufficient to induce kidney tissue hypoxia and initiate the development of kidney disease. Thus, interventions to prevent excessive mitochondrial QO 2 or to restore kidney tissue oxygen availability may prove beneficial to prevent nephropathy in diabetes mellitus and hypertension. 
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What Is New?
• This study demonstrates that increased kidney oxygen consumption and subsequent kidney tissue hypoxia are sufficient to induce nephropathy.
What Is Relevant?
• Most conditions associated with development of kidney disease also have confounding factors such as hyperglycemia or oxidative stress, which, per se, could contribute to disease development. By using 2,4-dinitrophenol to induce kidney hypoxia, we were able to demonstrate that hypoxia alone is sufficient to initiate disease development.
